|
?:authorAffiliation
|
-
[\'Department of Medicine, University of Washington School of Medicine, Seattle, Washington, USA.\', \'Ragon Institute of MGH, MIT and Harvard, Cambridge, Massachusetts, USA.\', \'PhD program in Immunology and Virology, University of Duisburg-Essen, Essen, Germany.\', \'PhD program in Virology, Division of Medical Sciences, Harvard University, Boston, Massachusetts, USA.\', \'Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.\', \'Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA.\', \'Providence Medical Group, Everett, Washington, USA.\', \'Department of Epidemiology and.\', \'Department of Laboratory Medicine and Pathology, University of Washington School of Medicine, Seattle, Washington, USA.\', \'Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.\', \'Department of Global Health, University of Washington, Seattle, Washington, USA.\', \'Benaroya Research Institute, Seattle, Washington, USA.\']
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}